HGS BioScience expands its platform with acquisition of Pharmgrade - High Plains Journal
3 days ago • Google News
HGS
NSEundefined 405.25-1.95%
Price Chart
Key Statistics
Market Cap
₹ 0
P/E Ratio
0.00
Revenue (TTM)
₹ 0
Volume
14.16K
52W High
₹ 0.00
52W Low
₹ 0.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
N/A
52 Week Low
N/A
About HGS
No description available.
Employees
N/A
Headquarters
N/A
CEO
N/A
Latest News
Akin Advises Paine Schwartz Partners and HGS BioScience in Acquisition of Pharmgrade - akingump.com
2 weeks ago • Google News
HGS Introduces AMLens: Accelerating AML Investigations with Explainable AI - PRWeb
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg